Clinical Trial Update: Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial assessing reduced-dose pegfilgrastim as support for chemotherapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Neutropenia | Phase 3 | Status: COMPLETED